Inhibitors of tyk2
US-2024425484-A1 · Dec 26, 2024 · US
Pyrimidine compounds for the treatment of cancer
US9771330B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9771330-B2 |
| Application number | US-201314647733-A |
| Country | US |
| Kind code | B2 |
| Filing date | Nov 22, 2013 |
| Priority date | Nov 27, 2012 |
| Publication date | Sep 26, 2017 |
| Grant date | Sep 26, 2017 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
Compounds of Formula I or II: are described, along with pharmaceutical compositions containing the same and methods of using such compounds for the treatment of cancer.
First claim
Opening claim text (preview).
That which is claimed is: 1. A compound having the following structure: and pharmaceutically acceptable salts thereof. 2. A composition comprising the compound of claim 1 in a pharmaceutically acceptable carrier. 3. A method of improving the condition of a cancer in a subject in need thereof, comprising administering to said subject the compound of claim 1 in an amount effective to improve the condition of said cancer, wherein said cancer is selected from the group consisting of myeloid leukemia, lymphoblastic leukemia, melanoma, breast, and colon cancer.
Assignees
Inventors
Classifications
Antineoplastic agents · CPC title
Peri-condensed systems · CPC title
Bridged systems · CPC title
- C07D239/48Primary
Two nitrogen atoms · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9771330B2 cover?
- Compounds of Formula I or II: are described, along with pharmaceutical compositions containing the same and methods of using such compounds for the treatment of cancer.
- Who is the assignee on this patent?
- Univ North Carolina Chapel Hill
- What technology area does this patent fall under?
- Primary CPC classification C07D239/48. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue Sep 26 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).